Your browser doesn't support javascript.
loading
Frameless image-guided radiosurgery for trigeminal neuralgia.
Shields, Lisa B E; Shanks, Todd S; Shearer, Andrew J; Shelton, Lauren A; Shelton, Brent J; Howe, Jonathan; Coons, James M; Plato, Brian; Spalding, Aaron C.
Afiliação
  • Shields LBE; Norton Neuroscience Institute, Norton Healthcare, Louisville, Kentucky, USA.
  • Shanks TS; The Brain Tumor Center, Norton Healthcare, Louisville, Kentucky, USA.
  • Shearer AJ; Norton Neuroscience Institute, Norton Healthcare, Louisville, Kentucky, USA.
  • Shelton LA; The Brain Tumor Center, Norton Healthcare, Louisville, Kentucky, USA.
  • Shelton BJ; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
  • Howe J; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
  • Coons JM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
  • Plato B; The Brain Tumor Center, Norton Healthcare, Louisville, Kentucky, USA.
  • Spalding AC; The Norton Cancer Institute Radiation Center and Kosair Children's Hospital, Louisville, Kentucky, USA.
Surg Neurol Int ; 8: 87, 2017.
Article em En | MEDLINE | ID: mdl-28607821
ABSTRACT

BACKGROUND:

Frameless image-guided radiosurgery (IGRS) is a safe and effective noninvasive treatment for trigeminal neuralgia (TN). This study evaluates the use of frameless IGRS to treat patients with refractory TN.

METHODS:

We reviewed the records of 20 patients diagnosed with TN who underwent frameless IGRS treatments between March 2012 and December 2013. Facial pain was graded using the Barrow Neurological Institute (BNI) scoring system. The initial setup uncertainty from simulation to treatment and the patient intrafraction uncertainty were measured. The median follow-up was 32 months.

RESULTS:

All patients' pain was BNI Grade IV or V before the frameless IGRS treatment. The mean intrafraction shift was 0.43 mm (0.28-0.76 mm), and the maximum intrafraction shift was 0.95 mm (0.53-1.99 mm). At last follow-up, 8 (40%) patients no longer required medications (BNI 1 or 2), 11 (55%) patients were pain free but required medication (BNI 3), and 1 (5%) patient had no pain relief (BNI 5). Patients who did not have prior surgery had a higher odds ratio for pain relief compared to patients who had prior surgery (14.9, P = 0.0408).

CONCLUSIONS:

Frameless IGRS provides comparable dosimetric and clinical outcomes to frame-based SRS in a noninvasive fashion for patients with medically refractory TN.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Surg Neurol Int Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Surg Neurol Int Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
...